GoodRx Holdings, Inc. (GDRX)

NASDAQ: GDRX · IEX Real-Time Price · USD
7.36
-0.24 (-3.16%)
At close: Aug 12, 2022 4:00 PM
7.42
+0.06 (0.82%)
After-hours: Aug 12, 2022 7:09 PM EDT
-3.16%
Market Cap 2.93B
Revenue (ttm) 803.49M
Net Income (ttm) -47.11M
Shares Out 398.13M
EPS (ttm) -0.04
PE Ratio n/a
Forward PE 25.84
Dividend n/a
Ex-Dividend Date n/a
Volume 6,625,107
Open 7.55
Previous Close 7.60
Day's Range 7.11 - 7.88
52-Week Range 5.62 - 48.05
Beta n/a
Analysts Buy
Price Target 9.60 (+30.4%)
Earnings Date Aug 8, 2022

About GDRX

GoodRx Holdings, Inc., through its subsidiaries, offers information and tools that enable consumers to compare prices and save on their prescription drug purchases in the United States. The company operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and access to negotiated prices through GoodRx codes that are used to save money on prescriptions across the United States. It also offers other healthcare products and services, including subscriptions, pharma manufacturer solutio... [Read more...]

Industry Health Care Technology
IPO Date Sep 23, 2020
Employees 756
Stock Exchange NASDAQ
Ticker Symbol GDRX
Full Company Profile

Financial Performance

In 2021, GDRX's revenue was $745.42 million, an increase of 35.36% compared to the previous year's $550.70 million. Losses were -$25.25 million, -91.40% less than in 2020.

Financial Statements

Analyst Forecast

According to 25 analysts, the average rating for GDRX stock is "Buy." The 12-month stock price forecast is 9.6, which is an increase of 30.43% from the latest price.

Price Target
$9.6
(30.43% upside)
Analyst Consensus: Buy
Stock Forecasts

News

ELV vs. GDRX: Which Stock Is the Better Value Option?

ELV vs. GDRX: Which Stock Is the Better Value Option?

Other symbols: ELV

GoodRx shares opened 30% up on Tuesday: how come?

Shares of GoodRx Holdings Inc (NASDAQ: GDRX) opened 30% up on Tuesday after the telemedicine company reported market-beating results for its fiscal second quarter. GoodRx Holdings Q2 earnings snapshot L...

GoodRx Looks to Win Back Customers at Time of Increased Need for Cost Relief

Pharmaceutical price-shopping platform GoodRx says it is pivoting to regain lost sales and customers now that it has settled a costly spat with a grocery chain's drug store, but warned the process would...

GoodRx Holdings, Inc. (GDRX) Q2 Earnings and Revenues Beat Estimates

GoodRx Holdings, Inc. (GDRX) delivered earnings and revenue surprises of 50% and 4.33%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

GoodRx stock rockets after earnings as company says snag with large grocer has been resolved

Shares of GoodRx Holdings Inc. were popping more than 30% in after-hours trading Monday after the company, which offers services for people looking to compare prescription drug prices, topped expectatio...

GoodRx Releases Second Quarter 2022 Financial Results

SANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx Holdings, Inc. (Nasdaq: GDRX), a leading consumer-focused digital healthcare platform, has released its second quarter 2022 financial results and posted a l...

GoodRx Offers Free Telehealth Appointments to Kentucky Residents Affected by Flooding

SANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx (Nasdaq: GDRX), a leading consumer-focused digital healthcare platform, today announced it is offering free online healthcare provider visits to Kentucky re...

Earnings Preview: GoodRx Holdings, Inc. (GDRX) Q2 Earnings Expected to Decline

GoodRx Holdings, Inc. (GDRX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

GoodRx to Present Virtually at the Bank of America SMID Cap Ideas Conference

SANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx Holdings, Inc. (Nasdaq: GDRX), a leading consumer-focused digital healthcare platform, today announced that management from the Company will be presenting v...

ELV vs. GDRX: Which Stock Should Value Investors Buy Now?

ELV vs. GDRX: Which Stock Is the Better Value Option?

Other symbols: ELV

Is GoodRx's Drop a Bear Market Opportunity?

The stock is down more than 85% from its 52-week high.

Is GoodRx a Growth Stock Worth Considering?

The company's large subscriber base is impressive.

GoodRx Announces Date for Second Quarter 2022 Earnings Release and Conference Call

SANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx Holdings Inc. (Nasdaq: GDRX), a leading consumer-focused digital healthcare platform, today announced it will release its second quarter 2022 financial resu...

Is This Distressed Growth Stock About to Make a Comeback?

Its business model is being put to the test, and it just might pass.

Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Continues Its Investigation of GoodRx Holdings, Inc...

LOS ANGELES , June 1, 2022 /PRNewswire/ --  Glancy Prongay & Murray LLP ("GPM"), a leading national shareholder rights law firm, continues its investigation on behalf of GoodRx Holdings, Inc. ("GoodRx" ...

INVESTOR ALERT: Law Offices of Howard G. Smith Continues Its Investigation of GoodRx Holdings, Inc. (GDRX) on Behalf ...

BENSALEM, Pa. , June 1, 2022 /PRNewswire/ -- Law Offices of Howard G.

The Law Offices of Frank R. Cruz Continues Its Investigation of GoodRx Holdings, Inc. (GDRX) on Behalf of Investors

LOS ANGELES , June 1, 2022 /PRNewswire/ -- The Law Offices of Frank R. Cruz continues its investigation of GoodRx Holdings, Inc. ("GoodRx" or the "Company") (NASDAQ: GDRX) on behalf of investors concern...

Kirby McInerney LLP Continues Investigation of Shareholder Claims on Behalf of GoodRx Holdings, Inc. (GDRX) Investors

NEW YORK--(BUSINESS WIRE)--The law firm of Kirby McInerney LLP is investigating potential claims against GoodRx Holdings, Inc. (“GoodRx” or the “Company”) (NASDAQ: GDRX). The investigation concerns whet...

2 Growth Stocks That Are Likely to Bounce Back This Year

These stocks are down, but investors shouldn't count them out.

Other symbols: ABNB

GoodRx and RxVantage Announce Strategic Relationship to Streamline Communications Between Providers and Manufacturers

SANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx (Nasdaq: GDRX), a leading consumer-focused digital healthcare platform, today announced a strategic relationship with RxVantage that will enable healthcare ...

2 Growth Stocks at All-Time Lows That Could Be the Ultimate Contrarian Buys

Investors shouldn't count these stocks out just yet.

Other symbols: PLTR

GOODRX ALERT: Bragar Eagel & Squire, P.C. Is Investigating GoodRx, Inc. on Behalf of GoodRx Stockholders and Encourag...

NEW YORK--(BUSINESS WIRE)-- #GDRX--Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against GoodRx Holdings, Inc. (“GoodRx” or the “Com...

Kirby McInerney LLP Announces an Investigation of Shareholder Claims on Behalf of GoodRx Holdings, Inc. (GDRX) Investors

NEW YORK--(BUSINESS WIRE)--The law firm of Kirby McInerney LLP is investigating potential claims against GoodRx Holdings, Inc. (“GoodRx” or the “Company”) (NASDAQ: GDRX). The investigation concerns whet...

Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of GoodRx Holdings, Inc. (G...

LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of GoodRx Holdings, In...

INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of GoodRx Holdings, Inc. (GDRX) on Behalf of I...

BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith announces an investigation on behalf of GoodRx Holdings, Inc. (“GoodRx” or the “Company”) (NASDAQ: GDRX) investors concerning the Company's...